Archives

by in
Entry Author Date Location
Celgene Puts $35M into VentiRx, Gets Option to Buy Cancer Drugmaker 10/03/12 Seattle
Exelixis and Onyx Await Their Cancer-Drug Fates 09/18/12 San Francisco
Alder Gets $3.5M Milestone as Bristol-Myers Starts Crohn’s Study 08/27/12 Seattle
San Diego Life Sciences Roundup: Amylin Buyout, PDUFA, & More 07/05/12 San Diego
Bristol-Myers Buys Amylin for $5.3B, Getting Diabetes Drugs 06/29/12 San Diego
Merck Bets $15M on Ambrx’s “Smart Bomb” Antibodies 06/18/12 San Diego
Bristol-Myers Wrangles Top Academics to Study Immunity in Cancer 06/07/12 New York
ASCO Wrap-Up: A Summary of This Week’s Cancer R&D Headlines 06/05/12 National
The 2012 New York ASCO Checklist 05/24/12 New York
Aveo Kidney Cancer Drug Shows Safety Edge in Pivotal Study 05/16/12 Boston
Targeted Cancer Drugs With Punch: The Next Big Class of Antibodies 05/16/12 National
NY’s Cancer Research Institute Looks to Boost Cancer Immunotherapy 05/09/12 New York
SD Life Sciences Roundup: Amylin, Illumina, AstraZeneca Acquires Ardea, & More 04/27/12 San Diego
Alder Biopharma Snags $38M To Charge Ahead With Antibody Drugs 04/19/12 Seattle
Oncothyreon Marches On With ‘Son of Stimuvax’ Cancer Vaccine 04/10/12 Seattle
Amylin Booms on Report it Rejected Bristol’s $3.5B Takeover Bid 03/28/12 San Diego
Vertex Stays in HepC Game, as All-Oral Combo Passes Small Study 02/23/12 Boston
Enanta Enters HepC Big Leagues, With $34M Upfront From Novartis 02/21/12 Boston
Will New Business Models Enhance or Endanger Drug Discovery? 02/16/12 National
Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race 01/24/12 Boston
A Good News-Bad News Night for Bristol’s Diabetes and Hepatitis Drugs 01/19/12 New York
Alnylam Gets First Hint of Effectiveness for RNAi Cholesterol-Lowering Drug 01/04/12 Boston
The Top 10 Traffic-Getting Stories at Xconomy San Diego 12/28/11 San Diego
A Sweet Deal: How Amira Reinvented Itself as a Drug Discovery Engine 12/23/11 San Diego
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups 12/22/11 Seattle
The Hepatitis C Market: Biotech’s Version of the Daytona 500 12/12/11 National
The Stroke Prevention War is On: FDA Approves J&J/Bayer Contender 11/07/11 New York
Ariad’s Second Cancer Drug Found Safer Than Expected in Early Review of Key Study 11/07/11 Boston
Roche Acquires Anadys, Wests Create $100M Fund, Johnson & Johnson Makes Room for 20 Startups, & More San Diego Life Sciences News 10/20/11 San Diego
Blaze Bioscience, Fred Hutch Spinoff with Zymo Vet at the Helm, Seeks to “Paint” Tumors 10/18/11 Seattle
Page 2 of 8 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  2. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Zillions of Biotech Conferences Want You. Which Should You Attend?
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.